Skip to Content
Not all colorectal cancer treatments are the same. Find out more >

Pegfilgrastim Pregnancy and Breastfeeding Warnings

Pegfilgrastim is also known as: Neulasta

Pegfilgrastim Pregnancy Warnings

Pegfilgrastim has been assigned to pregnancy category C by the FDA. Studies in pregnant rabbits have shown adverse effects with doses of 50 mcg/kg/dose, an amount approximately 4-fold higher than the recommended human dose. Doses of 200 to 250 mcg/kg/dose of filgrastim resulted in an increased incidence of abortions. Subcutaneous injections of pegfilgrastim of up to 1000 mcg/kg/dose administered every other day during the period of organogenesis in rats were not associated with an embryotoxic or fetotoxic outcome. There are no controlled data in human pregnancy. Pegfilgrastim is only recommended for use during pregnancy when benefit outweighs risk.

See references

Pegfilgrastim Breastfeeding Warnings

There are no data on the excretion of pegfilgrastim into human milk. The manufacturer recommends that caution be used when administering pegfilgrastim to nursing women.

See references

References for pregnancy information

  1. "Product Information. Neulasta (pegfilgrastim)." Amgen, Thousand Oaks, CA.

References for breastfeeding information

  1. "Product Information. Neulasta (pegfilgrastim)." Amgen, Thousand Oaks, CA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.